510(k) K261336

Xpert Respiratory Panel by Cepheid — Product Code QOF

K261336 is an FDA 510(k) premarket notification submitted by Cepheid for the device "Xpert Respiratory Panel". The FDA issued a decision of Substantially Equivalent on Sep 25, 2026. The device falls under product code QOF (Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents), a Class II device regulated under 21 CFR 866.3981. Cepheid has 52 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 25, 2026
Date Received
Apr 23, 2026
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Device Class
Class II
Regulation Number
866.3981
Review Panel
MI
Submission Type
510(k)

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.

Source: FDA 510(k) database entry for K261336. Report a data issue: hello@regdatalab.com.